Form 10-Q Pulse Biosciences, Inc. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Pulse Biosciences (PLSE) PT Lowered to $43 at H.C. Wainwright
November 16, 2021 6:38 AM ESTH.C. Wainwright analyst Swayampakula Ramakanth lowered the price target on Pulse Biosciences (NASDAQ: PLSE) to $43.00 (from $46.00) while maintaining a Buy rating.
The analyst commented, "Pulse reported 3Q21 financial results and held a conference call on November 15. During the quarter, while Pulse is... More
Pulse Biosciences, Inc. (PLSE) Tops Q3 EPS by 5c
November 15, 2021 5:05 PM ESTPulse Biosciences, Inc. (NASDAQ: PLSE) reported Q3 EPS of ($0.48), $0.05 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $574 thousand versus the consensus estimate of $190 thousand.
For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.
... More